David E Potter - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David E Potter

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Investigative Ophthalmology & Visual Science|March 28, 2009

Opioid receptor-activation: retina protected from ischemic injuryShahid Husain, David E Potter, Craig E Crosson

The Journal of Pharmacology and Experimental Therapeutics|January 27, 2004

Bremazocine increases C-type natriuretic peptide levels in aqueous humor and enhances outflow facilityDavid E Potter, Karen R M Russell, Marlina Manhiani

Pharmacology|May 31, 2002

Naphazoline-induced neuroendocrine changes: increases in ANP and cGMP levels, but suppression of NE, 3H-NE, and cAMP levels in rabbit eyesMiller J Ogidigben, Teh-Ching Chu, David E Potter

Cells, Tissues, Organs|July 5, 2002

Muscle-specific effects of hindlimb suspension and clenbuterol in mature male ratsLawrence E Wineski, Daniel A von Deutsch, Imad K Abukhalaf, et al.

Canadian Journal of Physiology and Pharmacology|April 1, 2003

Changes in muscle proteins and spermidine content in response to unloading and clenbuterol treatmentDaniel A von Deutsch, Imad K Abukhalaf, Lawrence E Wineski, et al.

Pharmacology|May 31, 2002

Effect of hindlimb suspension and clenbuterol treatment on polyamine levels in skeletal muscleImad K Abukhalaf, Daniel A von Deutsch, Lawrence E Wineski, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Investigative Ophthalmology & Visual Science|March 28, 2009

Opioid receptor-activation: retina protected from ischemic injuryShahid Husain, David E Potter, Craig E Crosson

The Journal of Pharmacology and Experimental Therapeutics|January 27, 2004

Bremazocine increases C-type natriuretic peptide levels in aqueous humor and enhances outflow facilityDavid E Potter, Karen R M Russell, Marlina Manhiani

Pharmacology|May 31, 2002

Naphazoline-induced neuroendocrine changes: increases in ANP and cGMP levels, but suppression of NE, 3H-NE, and cAMP levels in rabbit eyesMiller J Ogidigben, Teh-Ching Chu, David E Potter

Cells, Tissues, Organs|July 5, 2002

Muscle-specific effects of hindlimb suspension and clenbuterol in mature male ratsLawrence E Wineski, Daniel A von Deutsch, Imad K Abukhalaf, et al.

Canadian Journal of Physiology and Pharmacology|April 1, 2003

Changes in muscle proteins and spermidine content in response to unloading and clenbuterol treatmentDaniel A von Deutsch, Imad K Abukhalaf, Lawrence E Wineski, et al.

Pharmacology|May 31, 2002

Effect of hindlimb suspension and clenbuterol treatment on polyamine levels in skeletal muscleImad K Abukhalaf, Daniel A von Deutsch, Lawrence E Wineski, et al.

Pageof 2